Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Amar Bahloul"'
Autor:
Camille Nevoret, Nathalie Gervaise, Brigitte Delemer, Said Bekka, Bruno Detournay, Amine Benkhelil, Amar Bahloul, Geneviève d'Orsay, Alfred Penfornis
Publikováno v:
JMIR Diabetes, Vol 8, p e44277 (2023)
BackgroundFor patients with type 2 diabetes (T2D), calculating the daily dose of basal insulin may be challenging. Insulia is a digital remote monitoring solution that uses clinical algorithms to recommend basal insulin doses. A predecessor device wa
Externí odkaz:
https://doaj.org/article/8bf0e14906cc48baa51b10dfef4e8de6
Autor:
Eric Renard, Camille Nevoret, Sophie Borot, Brigitte Delemer, Kamel Mohammedi, Ariane Sultan, Amar Bahloul, Amine Benkhelil, Bruno Detournay, Alfred Penfornis
Publikováno v:
Médecine des Maladies Métaboliques. 17:81-87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aa31d84eec9256559f5f7005d6fdb13
https://doi.org/10.1016/j.mmm.2022.09.001
https://doi.org/10.1016/j.mmm.2022.09.001
Publikováno v:
Médecine des Maladies Métaboliques. 16:723-732
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9038ee2ac98ba092f6e1f9b320460f94
https://doi.org/10.1016/j.mmm.2022.06.005
https://doi.org/10.1016/j.mmm.2022.06.005
Autor:
Camille Nevoret, Nathalie Gervaise, Brigitte Delemer, Said Bekka, Bruno Detournay, Amine Benkhelil, Amar Bahloul, Geneviève d'Orsay, Alfred Penfornis
BACKGROUND For patients with type 2 diabetes (T2D), calculating the daily dose of basal insulin may be challenging. Insulia is a digital remote monitoring solution that uses clinical algorithms to recommend basal insulin doses. A predecessor device w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b461b219afefb5441604869698cfd43a
https://doi.org/10.2196/preprints.44277
https://doi.org/10.2196/preprints.44277
Publikováno v:
Médecine des Maladies Métaboliques. 15:537-541
Resume La reevaluation reguliere des traitements pharmacologiques est une des composantes essentielle du suivi des patients diabetiques de type 2 (DT2). Cette reevaluation repose en partie sur des regles d’arret et de maintien destinee a limiter un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::077ee9e9698246ce0e30620c90583e91
https://doi.org/10.1016/j.mmm.2021.03.005
https://doi.org/10.1016/j.mmm.2021.03.005
Autor:
Bernard Charbonnel, Bruno Detournay, Clement Teissier, Zahra Boultif, Ronan Roussel, Amar Bahloul
Publikováno v:
Diabetes Therapy
Introduction A second-generation basal insulin analogue insulin glargine 300 U/mL (Gla-300) has been marketed in France since June 2016. This real-world study was designed to assess persistence with Gla-300 and the prevalence of related hypoglycemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f300b50cf3fe82ba272c7d48b1d8c78b
https://doi.org/10.1007/s13300-020-00874-2
https://doi.org/10.1007/s13300-020-00874-2
Publikováno v:
Diabetes Therapy
Introduction This study aimed to determine, in close to real-life conditions, the efficacy and safety of switching from any basal insulin to insulin glargine 300 U/mL (Gla-300) in patients with uncontrolled type 2 diabetes (T2D). Methods This was an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8839c79ae1ed0f4821922cec6ab4a63e
http://europepmc.org/articles/PMC6965550
http://europepmc.org/articles/PMC6965550
Publikováno v:
PharmacoEconomics Open
Objective Our objectives were to describe the basal insulin treatment regimens most widely used in a real-world setting in France and to estimate the associated treatment costs in people with type 2 diabetes mellitus (T2DM). Methods A cross-sectional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567186c9ade5ebb7d211429450cbdbe1
https://pubmed.ncbi.nlm.nih.gov/33215332
https://pubmed.ncbi.nlm.nih.gov/33215332
Publikováno v:
Médecine des Maladies Métaboliques. 11:458-467
Resume Objectif Decrire les pratiques d’autosurveillance glycemique (ASG) en France chez les patients diabetiques de type 1 (DT1) ou 2 (DT2), et estimer : – la proportion de patients realisant une ASG selon la frequence recommandee ; – la propo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4634a7427ab6af18bf274835547e4cc
https://doi.org/10.1016/s1957-2557(17)30111-6
https://doi.org/10.1016/s1957-2557(17)30111-6
Autor:
Bruno Detournay, Pierre-Yves Benhamou, Amar Bahloul, Viviane Jeanbat, Danièle Durain, Bruno Guerci
Publikováno v:
Santé Publique. 29:229-240
Objectif : Decrire les pratiques d’auto-surveillance glycemique (ASG) chez les patients diabetiques de type 1 (DT1) ou 2 (DT2) et estimer la proportion de patients realisant une ASG selon la frequence recommandee, la proportion de patients respecta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3e062ab1644f2fb0913d99954a389c4
https://doi.org/10.3917/spub.172.0229
https://doi.org/10.3917/spub.172.0229